pxl.store / Shutterstock.com (The Royal Courts of Justice, where the English High Court is based.)
1 June 2015
English court grants Warner’s appeal in Lyrica second medical use case
The English Court of Appeal has said pharmaceutical company Warner-Lambert has a viable argument that Actavis indirectly infringed a second medical use patent covering Warner’s drug Lyrica (pregabalin).
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
28 July 2026 Years of litigation over biodegradable drug-delivery technology took another turn after the Federal Circuit delivered a significant win for the medical device maker.
27 July 2026 With billions in revenue set to disappear as patents expire, pharmaceutical giants are racing to acquire their way out of trouble. But are there other drivers behind the surge—and how long can the momentum last?
27 July 2026 The firm has added partners with expertise in life sciences, technology disputes and trademark strategy, alongside leadership changes at its Hong Kong affiliate.